Cargando…
Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes
INTRODUCTION: The purpose of this retrospective clinic chart review study was to determine the potential of a combination therapy (CT) consisting of γ-aminobutyric acid (GABA), a dipeptidyl peptidase-4 inhibitor (DPP-4i), and a proton pump inhibitor (PPI) to improve glycemic control as an adjunct to...
Autores principales: | Rabinovitch, Alexander, Koshelev, Daniil, Lagunas-Rangel, Francisco Alejandro, Kosheleva, Liudmila, Gavra, Tali, Schiöth, Helgi B., Levit, Shmuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246767/ https://www.ncbi.nlm.nih.gov/pubmed/37293502 http://dx.doi.org/10.3389/fendo.2023.1171886 |
Ejemplares similares
-
Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2022) -
Drosophila as a Rapid Screening Model to Evaluate the Hypoglycemic Effects of Dipeptidyl Peptidase 4 (DPP4) Inhibitors: High Evolutionary Conservation of DPP4
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2023) -
Can Exposure to Environmental Pollutants Be Associated with Less Effective Chemotherapy in Cancer Patients?
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2022) -
Clinical Use of DPP-4 Inhibitors
por: Gallwitz, Baptist
Publicado: (2019) -
GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials
por: Gilbert, Matthew P., et al.
Publicado: (2020)